Showing results (201-210 of 361) with videos related to

Sort By:
Pageof 37
Therapeutic Advances in Psychopharmacology|April 29, 2025
Reasons for discontinuing and restarting lithium multiple times: a case-register study based on the South London and Maudsley NHS Foundation Trust Clinical Record Interactive Search systemPetra Truedson, Kalliopi Vallianatou, Michael Ott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2018
Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma PatientsSwati Khanna, Suzanne Graef, Francis Mussai, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|February 6, 2025
Lost in translation? How context shapes the implementation of Competence by Design in operative settingsRachael Pack, Mary C Ott, Sayra Cristancho, et al.
Experimental and Molecular Pathology|July 2, 2003
PCR-based quantification of amplified RNA from laser microdissected mouse liver samplesTobias Cantz, Andrea Jochheim, Alexandra Cieslak, et al.
American Journal of Surgery|June 14, 2015
Thinking like an expert: surgical decision making as a cyclical process of being awareSayra M Cristancho, Tavis Apramian, Meredith Vanstone, et al.
The Journal of Infectious Diseases|June 26, 2009
Analysis of Plasmodium falciparum var genes expressed in children from Papua New GuineaNicole Falk, Mirjam Kaestli, Weihong Qi, et al.
La Radiologia Medica|December 10, 2024
Quantifying morphologic variations as an alternate to standard response criteria for unresectable primary liver tumors after checkpoint inhibition therapyLaetitia Saccenti, Nicole Varble, Tabea Borde, et al.
Investigational New Drugs|December 16, 2015
A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancerDustin A Deming, Ludmila L Cavalcante, Sam J Lubner, et al.
Anti-Cancer Drugs|September 23, 2009
Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'Stefan Boeck, Ursula Vehling-Kaiser, Dirk Waldschmidt, et al.
Clinical and Translational Science|April 3, 2021
A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotypeMarina Baretti, Enusha Karunasena, Marianna Zahurak, et al.
Pageof 37